Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Bregnhoj A, Thuesen KKH, Emmanuel T, Litman T, et al. HSP90 inhibitor RGRN-305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study. Br J Dermatol 2021 Nov 8. doi: 10.1111/bjd.20880.
PMID: 34748646


Privacy Policy